Skip to main content
Fig. 1 | Human Genomics

Fig. 1

From: Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics

Fig. 1

Manhattan plot of the significant associations of pharmacogenomics variants as identified in the GWAS studies deposited in the GWAS catalog. These variants have been associated with response to antipsychotic treatment. The red line denotes the genome-wide threshold of significance (p = 5× 10-8) and the blue line the suggestive threshold of significance (p = 10-5)

Back to article page

Human Genomics

ISSN: 1479-7364